All Stories

  1. Ongoing challenges to understanding multidrug- and rifampicin-resistant tuberculosis in children versus adults
  2. The potential impact of COVID-19-related disruption on tuberculosis burden
  3. The risk of multidrug or rifampicin-resistance in men versus women with TB